ºÝºÝߣ

evolution summit marcus evans clinical trials drug development drug discovery pharma pharmaceutical pharmaceutical marketing drug trials pharma evolution alexander fetkovsky pharmamarketing summit clinical development discovery summit evolution summits inc. sanaclis drug evolution marketing life sciences evolution deepen patel kenneth kaitin topstone research sonia sethi pharmaceuticals interview veristat clinical research syndax hematology oncology drug development biomarkers clinical trial standardization primorus clinical trials localization biorasi multitouch marketing pharmaceutical development hispanic patients maximizing procedure site identification patient recruitment & retention tufts clinart mena alaa assem business development activities interview - clinar lundbeck interactive corporation drugdev sanaclis s.r.o. conducting clinical trials in emerging markets wit marcus evans evolution summit 2015 clinical trial efficiency should be a key focus suvro ghosh clinzen llc acurian roger smith why quantitative comparison of patient recruitment staffan gestrelius capish tom mccourt modeling and simulation technologies in silco to in vivo optimized drug development drug discovery summit pharma marketing chief marketing officers alkermes cmos jim fratantonio kristine koontz clinical trial supply chain clinical trial operations pharmabrand bayer pharmaceuticals erwin de beuckelaer summit janssen pharmaceuticals where marcus evans fits in our business developmen biomedical research biotech pharmabrand summit biopharma medication administration long-term care cxo summit patient recruitment forest research institute telemedicine ind global regulatory strategy new drug development cta translational medicine non-porfits medical research foundation ironwood pharmaceutical clinical study feasibility process clinical study evolution asia abbvie pharma r&d big-data opportunities kyle holen clinical trials in europe cros clinical study metrics clinical trial data management mark wingertzahn glaxosmithcline patient centricity eirini schlosser evolution europe steven fruchtman onconova therapeutics roman hrynchuk clinical trial patient recruitment ind application fda kevin hennegan kathleen boruchowski medical monitors fox chase cancer center ipsen risk based monitoring lori tierney allergan ascendis pharma dunya botetzayas risk-based monitoring clinical studies chief marketing officer cmo icon plc decentralized trials evolution summit 2015 idiopathic pulmonary fibrosis keith parent boehringer ingelheim pharmaceuticals andreas grauer amgen tufts center eisai pharmceuticals johan luthman gary romano johnson and johnson visiopharm image analysis court square group inc. drug development challenges disease treatment pharma industry patient records chitra lele drug safety clinical study health patient emrollment graeme ladds drug safety data pharsafer dyania health topstone research inc patient enrollment clicnical trials pharma discovery eb mclindon hybrid trials kelley kendle synchrogenix